BAXTER INTERNATIONAL INC shares rose 5% late evening after reporting first-quarter adjusted EPS of $0.36, beating analyst estimates of $0.31. Revenue reached $2.70B, exceeding the $2.62B expected as demand for medical devices remained strong. The steady performance provides relief to investors following a series of surprise misses and guidance downgrades last year.

Mitigating Geopolitical and Energy Volatility